These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36299182)

  • 1. [The companion diagnostics of targeted therapy and immunotherapy for hepatocellular carcinoma].
    Huang XW; Liu SH; Zhao JM
    Zhonghua Gan Zang Bing Za Zhi; 2022 Sep; 30(9):912-917. PubMed ID: 36299182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiality of immunotherapy against hepatocellular carcinoma.
    Tsuchiya N; Sawada Y; Endo I; Uemura Y; Nakatsura T
    World J Gastroenterol; 2015 Sep; 21(36):10314-26. PubMed ID: 26420958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutics for advanced hepatocellular carcinoma: Recent advances, current dilemma, and future directions.
    Zhu J; Yin T; Xu Y; Lu XJ
    J Cell Physiol; 2019 Aug; 234(8):12122-12132. PubMed ID: 30644100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical advances in targeted therapy and immunotherapy for hepatocellular carcinoma].
    Zhang DZ; Niu JQ
    Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):834-837. PubMed ID: 31941237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug research and development and unmet needs for advanced-stage hepatocellular carcinoma].
    Zhou HB; Hu HP
    Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):306-311. PubMed ID: 38733184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Hepatocellular carcinoma: A life-threatening disease".
    Chacko S; Samanta S
    Biomed Pharmacother; 2016 Dec; 84():1679-1688. PubMed ID: 27823920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging drugs for the treatment of hepatocellular carcinoma.
    Ayoub WS; Jones PD; Yang JD; Martin P
    Expert Opin Emerg Drugs; 2022 Jun; 27(2):141-149. PubMed ID: 35642526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic treatment of advanced hepatocellular cancer: new hope on the horizon.
    Chang Lee R; Tebbutt N
    Expert Rev Anticancer Ther; 2019 Apr; 19(4):343-353. PubMed ID: 30793991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for hepatocellular carcinoma: current status and future perspectives.
    Ikeda M; Morizane C; Ueno M; Okusaka T; Ishii H; Furuse J
    Jpn J Clin Oncol; 2018 Feb; 48(2):103-114. PubMed ID: 29253194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research Progresses of Targeted Therapy and Immunotherapy for Hepatocellular Carcinoma.
    Wang T; Zhang Q; Wang N; Liu Z; Zhang B; Zhao Y
    Curr Med Chem; 2021; 28(16):3107-3146. PubMed ID: 33050856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Therapy for Primary Liver Tumors: Cholangiocarcinoma and Hepatocellular Carcinoma.
    Sadeghi S; Bejjani A; Finn RS
    Surg Oncol Clin N Am; 2019 Oct; 28(4):695-715. PubMed ID: 31472914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma: systemic therapies and future perspectives.
    Mikhail S; Cosgrove D; Zeidan A
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1205-18. PubMed ID: 25199765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The advanced development of molecular targeted therapy for hepatocellular carcinoma.
    Yan T; Yu L; Zhang N; Peng C; Su G; Jing Y; Zhang L; Wu T; Cheng J; Guo Q; Shi X; Lu Y
    Cancer Biol Med; 2022 Jun; 19(6):802-17. PubMed ID: 35699406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma: an update on investigational drugs in phase I and II clinical trials.
    Noonan A; Pawlik TM
    Expert Opin Investig Drugs; 2019 Nov; 28(11):941-949. PubMed ID: 31590579
    [No Abstract]   [Full Text] [Related]  

  • 15. The application of nanoparticles in immunotherapy for hepatocellular carcinoma.
    Hu X; Zhu H; He X; Chen J; Xiong L; Shen Y; Li J; Xu Y; Chen W; Liu X; Cao D; Xu X
    J Control Release; 2023 Mar; 355():85-108. PubMed ID: 36708880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer treatments for advanced hepatocellular carcinoma.
    Song MJ; Bae SH
    Korean J Intern Med; 2014 Mar; 29(2):149-55. PubMed ID: 24648795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of hepatocellular carcinoma: strategies for combinatorial intervention.
    Tian M; Shi Y; Liu W; Fan J
    Sci China Life Sci; 2019 Sep; 62(9):1138-1143. PubMed ID: 31119560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: new therapeutic interventions for advanced hepatocellular carcinoma.
    Bangaru S; Marrero JA; Singal AG
    Aliment Pharmacol Ther; 2020 Jan; 51(1):78-89. PubMed ID: 31747082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment.
    Yegin EG; Oymaci E; Karatay E; Coker A
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):234-56. PubMed ID: 27298100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinase inhibitors as potential sensitizers of adoptive T cell therapy for hepatocellular carcinoma.
    Liang L; Wang X; Huang S; Chen Y; Zhang P; Li L; Cui Y
    Front Immunol; 2023; 14():1046771. PubMed ID: 36936932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.